BioTime Provides Financing and Product Development Update
ALAMEDA, Calif. BioTime, Inc. (NYSE MKT: BTX) today announced the results of its capital raising activities since October 1, 2013 through its $25 million Controlled Equity Offering facility, and...
View ArticleR-Tech Ueno: Announcement of Collaborative Research with Keio University for...
TOKYO R-Tech Ueno, Ltd. (JASDAQ:4573): We announce the launch of a collaborative research on graft-versus-host disease (GVHD) with Professor Kazuo Tsubota’s group, Department of Ophthalmology, Keio...
View ArticleMenicon Chairman’s Lifetime Achievements Recognized
Smart Multimedia Gallery M. T. Contact Lens, the first corneal contact lens in Japan, 1953. (Photo: Business Wire) View and Share Photo Download Small Encounter with the American officer’s wife at...
View ArticlepSivida Corp. Announces $7.0 Million Investment by RA Capital
WATERTOWN, Mass. pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that RA Capital...
View ArticleApl.de.ap Foundation International Joins With Children’s Hospital Los Angeles...
LOS ANGELES During a press conference at Children’s Hospital Los Angeles (CHLA) today, Black Eyed Peas star Apl.de.ap announced that his charity, Apl.de.ap Foundation International (ADAFI), will...
View ArticleLapmaster宣布收购Peter Wolters
伊利诺伊州芒特普罗斯佩克特 (美国商业资讯)–领先的高精度精磨、抛光、研磨、珩磨设备与服务提供商Lapmaster Group Holdings LLC今天宣布,该公司已收购Peter Wolters GmbH,后者是一家高精度表面处理机床和系统提供商。中间市场投资银行公司Headwaters MB在此项交易中为Lapmaster提供咨询服务。 Lapmaster总裁兼首席执行官Brian...
View Articleラップマスターがピーターウォルターズの買収を発表
米イリノイ州マウントプロスペクト (ビジネスワイヤ)– ラッピング、研磨、研削、ホーニング向けの高精度機器・サービスを提供する一流企業のラップマスター・グループ・ホールディングスは本日、高精度表面処理向けの工作機械とシステムを提供するピーターウォルターズを買収したと発表しました。本取引では、中間市場向け投資銀行のヘッドウォーターズMBがラップマスターの顧問を務めました。...
View ArticleNUNEMISO Eye Center: Korean Dr.Koo’s Outstanding Performance on SMILE
SEOUL, South Korea There have been several kinds of Vision Correction Surgery: LASIK, LASEK, and ICL. However, recently medical teams of ophthalmology include SMILE as another innovative vision...
View ArticleNUNEMISO Eye Center : Dr.Koo in Korea at the Top of the World with SMILE
SEOUL, South Korea Dr.Hyung-jin Koo in Korea, who is a world widely recognized medical member of ophthalmology with outstanding medical skills of SMILE, released his operating result of SMILE, which...
View ArticleChinese FDA Accepts Phase 2 IND for RGN-259 for Dry Eye
ROCKVILLE, Md. RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) (“RegeneRx”) and Lee’s Pharmaceutical Holdings Ltd. (“Lee’s”) today jointly announced that the Chinese FDA has accepted a Phase II IND...
View ArticlepSivida Corp. Reports Positive Regulatory Outcome for ILUVIEN®; Moves to...
WATERTOWN, Mass. pSivida Corp. (NASDAQ: PSDV)(ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the regulatory...
View ArticleRegeneRx’s Strategic Partner G-treeBNT Preparing for Phase III Dry Eye Trials...
ROCKVILLE, Md. RegeneRx Pharmaceuticals (OTCBB:RGRX), and G-treeBNT Co. Ltd., a Korean biotech firm, jointly announced today that G-treeBNT is preparing to file an IND and sponsor a Phase III...
View ArticleLetter to NovaBay Shareholders
EMERYVILLE, Calif. NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on non-antibiotic anti-infectives, announced today the distribution of a letter from Ron...
View ArticleNeuroVision Imaging Eye Test Shows Potential for Early Detection of Changes...
SACRAMENTO, Calif. NeuroVision Imaging, LLC announced today that preliminary results of a major clinical trial show the company’s investigational noninvasive imaging system appeared to detect...
View ArticleWearable Device for the Early Detection of Common Diabetes-related...
WASHINGTON A group of researchers in Taiwan has developed a new optical technology that may be able to detect an early complication of diabetes sooner, when it is more easily treated. If the device...
View ArticleHoya Announces First Quarter Financial Results
TOKYO HOYA Corporation (TOKYO:7741) today announced financial results for the first quarter ended June 30, 2014. For the quarter under review, group sales increased 12.6% to 113,071 million yen...
View ArticleInvestment Bridge Announces Investment Opinion: Bridge Report on R-Tech Ueno...
TOKYO Investment Bridge, one of Japan’s leading independent IR services companies, has released a “Bridge Report” on R-Tech Ueno, Ltd. (JASDAQ:4573) reviewing the results for the fiscal year March...
View ArticleFabrinet Announces Audit Committee Investigation into Accounting Matters;...
BANGKOK Fabrinet (NYSE:FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of...
View ArticleNovaBay Announces Results of NVC-422 Phase 2 for Viral Conjunctivitis
EMERYVILLE, Calif. NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY) announced today that its NVC-422 ophthalmic formulation did not meet the primary or secondary endpoints in a Phase 2 clinical study in...
View ArticleChina’s Food and Drug Administration has Cleared NovaBay’s NeutroPhase Skin...
EMERYVILLE, Calif. & SHANGHAI NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective...
View Article